| dc.creator |
Font de Mora, Jaime |
|
| dc.creator |
Esteban, Luis Miguel |
|
| dc.creator |
Burks, Deborah J. |
|
| dc.creator |
Núñez, Alejandro |
|
| dc.creator |
Garcés, Carmen |
|
| dc.creator |
García-Barrado, María José |
|
| dc.creator |
Iglesias-Osma, María Carmen |
|
| dc.creator |
Moratinos, Julio |
|
| dc.creator |
Santos de Dios, Eugenio |
|
| dc.date |
2008-06-17T11:26:30Z |
|
| dc.date |
2008-06-17T11:26:30Z |
|
| dc.date |
2003-06 |
|
| dc.date.accessioned |
2017-01-31T01:42:39Z |
|
| dc.date.available |
2017-01-31T01:42:39Z |
|
| dc.identifier |
EMBO J. 2003 June 16; 22(12): 3039–3049 |
|
| dc.identifier |
1460-2075 |
|
| dc.identifier |
http://hdl.handle.net/10261/5139 |
|
| dc.identifier |
10.1093/emboj/cdg280 |
|
| dc.identifier.uri |
http://dspace.mediu.edu.my:8181/xmlui/handle/10261/5139 |
|
| dc.description |
Final full-text version of the paper available at: http://www.nature.com/emboj/journal/v22/n12/index.html |
|
| dc.description |
Development of diabetes generally reflects an inadequate mass of insulin-producing β-cells. β-cell proliferation and differentiation are regulated by a variety of growth factors and hormones, including insulin-like growth factor I (IGF-I). GRF1 is a Ras-guanine nucleotide exchange factor known previously for its restricted expression in brain and its role in learning and memory. Here we demonstrate that GRF1 is also expressed in pancreatic islets. Interest ingly, our GRF1-deficient mice exhibit reduced body weight, hypoinsulinemia and glucose intolerance owing to a reduction of β-cells. Whereas insulin resistance is not detected in peripheral tissues, GRF1 knockout mice are leaner due to increased lipid catabolism. The reduction in circulating insulin does not reflect defective glucose sensing or insulin production but results from impaired β-cell proliferation and reduced neogenesis. IGF-I treatment of isolated islets from GRF1 knockouts fails to activate critical downstream signals such as Akt and Erk. The observed phenotype is similar to manifestations of preclinical type 2 diabetes. Thus, our observations demonstrate a novel and specific role for Ras-GRF1 pathways in the development and maintenance of normal β-cell number and function. |
|
| dc.description |
This work was
supported by FEDER grants 1FD97-1735 and 1FD97-1678 and CICYT
grant SAF00-0069 from MCYT (Spain). J.F.d.M. and D.J.B. were
financed by the Ramón y Cajal Program from MCYT (Spain). |
|
| dc.description |
Peer reviewed |
|
| dc.format |
22195 bytes |
|
| dc.format |
application/pdf |
|
| dc.language |
eng |
|
| dc.publisher |
Nature Publishing Group |
|
| dc.rights |
openAccess |
|
| dc.subject |
Cell growth |
|
| dc.subject |
β-cells |
|
| dc.subject |
Differentiation |
|
| dc.subject |
Differentiation |
|
| dc.subject |
Insulin |
|
| dc.subject |
Ras-GRF1 |
|
| dc.title |
Ras-GRF1 signaling is required for normal β-cell development and glucose homeostasis |
|
| dc.type |
Artículo |
|